Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the Fourth Quarter of on Wednesday, November 4, prior to the opening of trading on the New York Stock Exchange.
Participating in the conference call will be:
Robert P. Mauch, President & Chief Executive Officer
Eva C. Boratto, Executive Vice President & Chief Financial Officer
The live call will be webcast via the Company’s website at investor.cencora.com. Users are encouraged to log on to the webcast approximately 10 minutes in advance of the scheduled start time of the call.
A replay of the webcast will be posted on investor.cencora.com approximately one hour after the completion of the call and will remain available for one year.
Cencora is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. Cencora partners with pharmaceutical innovators across the value chain to facilitate and optimize market access to therapies.
Care providers depend on Cencora for the secure, reliable delivery of pharmaceuticals, healthcare products, and solutions. Cencora’s worldwide team members contribute to positive health outcomes through the power of Cencora’s purpose: Cencora is united in its responsibility to create healthier futures. Cencora is ranked #10 on the Fortune 500 and #16 on the Global Fortune 500 with more than $300 billion in annual revenue.
COR shares descended $5.48, or 1.8%, to $304.30.
